Your session is about to expire
← Back to Search
PTSD Mobile App for Cancer Survivors
Study Summary
This trial is testing a stepped-care approach to treating PTSD symptoms in stem cell transplant survivors, which may help develop targeted treatments for PTSD.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing and able to do a one-hour interview.You have severe PTSD symptoms related to cancer, which may include flashbacks, nightmares, or avoidance of certain situations. Or you have mild PTSD symptoms, such as re-experiencing events related to cancer and a few other symptoms.I have not had cognitive behavioral therapy for PTSD.I had a stem cell transplant between 1 and 5 years ago.My cancer is in remission and I may be on preventive treatment.You have a device like a phone or tablet that can connect to the internet and send emails.
- Group 1: CaDC and mCoaching
- Group 2: Cancer Distress Coach (CaDC)
- Group 3: Control
- Group 4: mCBT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are seniors aged 60 and above able to participate in this medical trial?
"Eligibility for the trial requires that prospective participants are over 18 and under 85 years of age."
How many individuals are projected to join this experiment?
"Affirmative, according to the clinicaltrials.gov information this trial is currently seeking participants. This research project was first published on 24th January 2021 and received its most recent update on 26th January 2022; it seeks 400 individuals from 2 locations."
Does this clinical trial still require participants?
"As per clinicaltrials.gov, the medical trial is actively seeking out patients; this investigation was published on January 24th 2021 and underwent its last amendment on January 26th 2022."
What criteria must a person meet to qualify for the research trial?
"This study is seeking 400 individuals aged 18 to 85 with diagnosed malignancies. In addition, qualified participants must have either undergone autologous or allogeneic hematopoietic stem cell transplantation 1-5 years prior; achieved partial or complete remission (NED); not suffer from serious psychological impairment such as suicidality requiring hospitalization; be approved by their oncologist for participation in the trial; agree to a one hour baseline interview; not had CBT previously for PTSD; own and operate an internet capable device with email access; possess basic literacy of English language, and exhibit probable cancer related post traumatic stress"
Share this study with friends
Copy Link
Messenger